Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
BJU International|March 18, 2023
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia timeDaniele Cignoli, Giuseppe Basile, Giuseppe Fallara, et al.
World Journal of Urology|December 31, 2024
Identifying optimal candidates for active surveillance in low-grade intermediate-risk non-muscle invasive bladder cancerPaolo Zaurito, Pietro Scilipoti, Mattia Longoni, et al.
Urologic Oncology|June 6, 2022
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinomaGiuseppe Basile, Giuseppe Rosiello, Alessandro Larcher, et al.
World Journal of Urology|April 28, 2024
Peri- and post-operative outcomes of robot-assisted radical cystectomy after the implementation of the EAU guidelines recommendations for collecting and reporting complications at a high-volume referral centerFranceso Pellegrino, Riccardo Leni, Giuseppe Basile, et al.
Urologic Oncology|July 28, 2026
Sex-based differences in peri-operative and long-term oncologic outcomes after primary surgical treatment for kidney cancer: A comprehensive analysis from a high-volume tertiary centerAlessandro Bertini, Chiara Re, Lucia Salerno, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 14, 2022
The effect of frailty on post-operative outcomes and health care expenditures in patients treated with partial nephrectomyGiuseppe Rosiello, Chiara Re, Alessandro Larcher, et al.
Urologic Oncology|February 10, 2022
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinomaGiuseppe Rosiello, Alessandro Larcher, Giuseppe Fallara, et al.
Urologic Oncology|April 21, 2024
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancerFrancesco Cei, Alessandro Larcher, Giuseppe Rosiello, et al.
BJU International|April 15, 2024
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patientsMattia Longoni, Pietro Scilipoti, Chiara Re, et al.
World Journal of Urology|September 20, 2022
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most?Giuseppe Fallara, Alessandro Larcher, Giuseppe Rosiello, et al.
Pageof 5